OFFICE LOCATIONS:
BURKE PHARMACEUTICAL RESEARCH
3633 Central Avenue, Suite I
Hot Springs, Arkansas, 71913

Licensure in the following states:
Arkansas
Ohio
North Carolina
Pennsylvania (Inactive)

Telephone: (501) 620-4449
Fax:(501) 321-2886
E-mail: mstarns@burkepharmaceutical.com

EDUCATION:
Master of Physician Assistant Studies
Chatham College, Pittsburgh, Pennsylvania, 2001
• Clinical Rotations: Primary Care, Pediatrics, Orthopedics, Neurology, Obstetrics & Gynecology, General Surgery, Rehabilitation Medicine, Psychiatry, and Emergency Medicine

Master of Science in Zoology
Miami University, Oxford, Ohio, 1975
• Graduate Teaching Assistant with Anatomy and Physiology

Bachelor of Arts in Biology
Ottawa University, Ottawa, Kansas, 1973
• Comprehensive Exams Passed With Distinction

Graduate of EMT-Paramedic Program
Aultman Hospital, Canton, Ohio, 1995

CERTIFICATIONS & REGISTRATIONS:
DEA Registration - Active
ACLS, BTLS, CPR – Current

MEMBERSHIPS:
(AAPA) American Academy of Physician Assistants (ARAPA) Arkansas Academy of Physician Assistants
(NCCPA) National Commission on Certification of Physician Assistants
(SDPA) Society of Dermatology Physician Assistants
(NCAPA) North Carolina Association of Physician Assistants

EMPLOYMENT HISTORY:
BURKE PHARMACEUTICAL RESEARCH
Hot Springs, Arkansas –December 2004 – present
Clinical Trial Sub Investigator

THE DERMATOLOGY CLINIC
Hot Springs, Arkansas - December 2004 – present
General dermatology

ADVANCED DERMATOLOGY CENTER
Gastonia & Huntersville, North Carolina – May2004 – November 2004
General dermatology, Mohs surgical assisting.

CAROLINA SKIN CARE
Pinehurst, North Carolina – July 2003 – October 2003 (FT Temporary position for PA maternity leave)
General dermatology

OHIO STATE UNIVERSITY MEDICAL CENTER & JAMES CANCER HOSPITAL
Columbus, Ohio – October 2001-October2002
Cardiothoracic surgical assisting and Oncology

CLINICAL TRIALS:
Phase I – Nasal Spray treatment for Pediatric (2-12) Allergic Rhinitis
Phase III – Topical Treatment for Seborrheic Dermatitis
Phase III – Topical Treatment for Tinea Pedis
Phase III – Topical Treatment for Mild to Severe Atopic Dermatitis
Phase III – Injection Treatment for Moderate to Severe Plaque Psoriasis

THE ABOVE CLINICAL TRIALS WERE CONDUCTED BY THE FOLLOWING COMPANIES:
Barrier
Connetics
Glaxo/SmithKline
Paddock
PRA International
Serono
Symbio

INDICATIONS:
Atopic Dermatitis
Tinea Pedis
Seborrheic Dermatitis
Psoriasis
Allergic Rhinitis

PUBLICATION:
Principal Investigator, Master’s Project Research Group: “Assessment of Patient Knowledge Regarding The Benefit of Physical Activity for Depressed Mood” presented American Academy of Physician Assistants Poster Presentation, AAPA National Conference, May 2001

COMMUNITY SERVICE:
HUDSON EMERGENCY MEDICAL SERVICE
Hudson, Ohio 1993-1999
NREMT-PARAMEDIC